159 related articles for article (PubMed ID: 17574687)
1. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
[TBL] [Abstract][Full Text] [Related]
2. Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.
Winters B; Van Craenenbroeck E; Van der Borght K; Lecocq P; Villacian J; Bacheler L
J Virol Methods; 2009 Dec; 162(1-2):101-8. PubMed ID: 19654022
[TBL] [Abstract][Full Text] [Related]
3. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
4. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nine resistance interpretation systems for HIV-1 genotyping.
Stürmer M; Doerr HW; Staszewski S; Preiser W
Antivir Ther; 2003 Jun; 8(3):239-44. PubMed ID: 12924541
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
[TBL] [Abstract][Full Text] [Related]
7. Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization.
Rabinowitz M; Myers L; Banjevic M; Chan A; Sweetkind-Singer J; Haberer J; McCann K; Wolkowicz R
Bioinformatics; 2006 Mar; 22(5):541-9. PubMed ID: 16368772
[TBL] [Abstract][Full Text] [Related]
8. Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
DiRienzo AG; DeGruttola V; Larder B; Hertogs K
Stat Med; 2003 Sep; 22(17):2785-98. PubMed ID: 12939786
[TBL] [Abstract][Full Text] [Related]
9. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
[TBL] [Abstract][Full Text] [Related]
10. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
Flandre P; Chappey C; Marcelin AG; Ryan K; Maa JF; Bates M; Seekins D; Bernard MC; Calvez V; Molina JM
J Infect Dis; 2007 Feb; 195(3):392-8. PubMed ID: 17205478
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of variation in tenofovir drug susceptibility in HIV-1.
Murray RJ; Lewis FI; Miller MD; Brown AJ
AIDS; 2008 Jun; 22(10):1113-23. PubMed ID: 18525256
[TBL] [Abstract][Full Text] [Related]
14. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
[TBL] [Abstract][Full Text] [Related]
16. A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.
Van Houtte M; Picchio G; Van Der Borght K; Pattery T; Lecocq P; Bacheler LT
J Med Virol; 2009 Oct; 81(10):1702-9. PubMed ID: 19697398
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
Wirden M; Lambert-Niclot S; Marcelin AG; Schneider L; Ait-Mohand H; Brunet C; Angleraud F; Amard S; Katlama C; Calvez V
AIDS; 2009 Jan; 23(1):95-9. PubMed ID: 19050391
[TBL] [Abstract][Full Text] [Related]
19. On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
Flandre P; Costagliola D
AIDS; 2006 Oct; 20(16):2118-20. PubMed ID: 17053360
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].
Rodriguez-Escudero MJ; Prada de Medio E; Rosa Herranz C; Martinez Medina MC; Franquelo Gutierrez R
Rev Esp Quimioter; 2007 Jun; 20(2):203-5. PubMed ID: 17893756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
